Bills in Congress Could Cut Medicare Drug Prices — and Impact MSAs

Two measures that appear to be gaining steam in Congress could give Medicare unprecedented control over drug prices, raising new questions about how lower costs would affect the world of Medicare set-aside agreements. Set-aside experts said lowered costs for Medicare could mean that smaller slices of settlements would go to Medicare, and some workers already bound by MSAs could see a financial gain because of that. Drug spending typically makes up almost a quarter of the total amount of settlements with MSAs. And some stakeholders are now debating if reduced costs will make settlements more ...